Annual Total Long Term Liabilities
$29.43 B
+$2.62 B+9.79%
December 31, 2024
Summary
- As of February 7, 2025, NVS annual total long term liabilities is $29.43 billion, with the most recent change of +$2.62 billion (+9.79%) on December 31, 2024.
- During the last 3 years, NVS annual total long term liabilities has fallen by -$4.34 billion (-12.84%).
- NVS annual total long term liabilities is now -22.67% below its all-time high of $38.05 billion, reached on December 31, 2020.
Performance
NVS Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$29.43 B
-$2.52 B-7.90%
December 31, 2024
Summary
- As of February 7, 2025, NVS quarterly total long term liabilities is $29.43 billion, with the most recent change of -$2.52 billion (-7.90%) on December 31, 2024.
- Over the past year, NVS quarterly long term liabilities has increased by +$2.62 billion (+9.79%).
- NVS quarterly long term liabilities is now -32.01% below its all-time high of $43.29 billion, reached on September 30, 2020.
Performance
NVS Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
NVS Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.8% | +9.8% |
| 3 y3 years | -12.8% | +12.9% |
| 5 y5 years | -14.8% | +12.9% |
NVS Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -12.8% | +9.8% | -12.8% | +16.4% |
| 5 y | 5-year | -22.7% | +9.8% | -32.0% | +16.4% |
| alltime | all time | -22.7% | +393.9% | -32.0% | +408.4% |
Novartis AG Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $29.43 B(+9.8%) | $29.43 B(-7.9%) |
| Sep 2024 | - | $31.95 B(+14.1%) |
| Jun 2024 | - | $27.99 B(+10.7%) |
| Mar 2024 | - | $25.29 B(-5.7%) |
| Dec 2023 | $26.80 B(-8.7%) | $26.80 B(+2.9%) |
| Sep 2023 | - | $26.06 B(-4.0%) |
| Jun 2023 | - | $27.14 B(-8.2%) |
| Mar 2023 | - | $29.55 B(+0.6%) |
| Dec 2022 | $29.37 B(-13.0%) | $29.37 B(-0.1%) |
| Sep 2022 | - | $29.41 B(-8.8%) |
| Jun 2022 | - | $32.26 B(-4.3%) |
| Mar 2022 | - | $33.71 B(-0.2%) |
| Dec 2021 | $33.77 B(-11.3%) | $33.77 B(-1.8%) |
| Sep 2021 | - | $34.39 B(-14.6%) |
| Jun 2021 | - | $40.25 B(-1.8%) |
| Mar 2021 | - | $41.00 B(+7.8%) |
| Dec 2020 | $38.05 B(+10.1%) | $38.05 B(-12.1%) |
| Sep 2020 | - | $43.29 B(+6.9%) |
| Jun 2020 | - | $40.50 B(-0.8%) |
| Mar 2020 | - | $40.83 B(+18.1%) |
| Dec 2019 | $34.55 B(-7.3%) | $34.55 B(-1.7%) |
| Sep 2019 | - | $35.15 B(+1.4%) |
| Jun 2019 | - | $34.68 B(+0.5%) |
| Mar 2019 | - | $34.51 B(-7.4%) |
| Dec 2018 | $37.26 B(+5.1%) | $37.26 B(+1.7%) |
| Sep 2018 | - | $36.65 B(-1.5%) |
| Jun 2018 | - | $37.21 B(+3.1%) |
| Mar 2018 | - | $36.09 B(+1.8%) |
| Dec 2017 | $35.45 B(+7.3%) | $35.45 B(-4.8%) |
| Sep 2017 | - | $37.22 B(-1.1%) |
| Jun 2017 | - | $37.63 B(-1.0%) |
| Mar 2017 | - | $38.01 B(+15.1%) |
| Dec 2016 | $33.02 B(+7.5%) | $33.02 B(-3.8%) |
| Sep 2016 | - | $34.34 B(+5.2%) |
| Jun 2016 | - | $32.63 B(-0.3%) |
| Mar 2016 | - | $32.74 B(+6.6%) |
| Dec 2015 | $30.73 B(+11.4%) | $30.73 B(+9.8%) |
| Sep 2015 | - | $27.98 B(+2.9%) |
| Jun 2015 | - | $27.19 B(-7.6%) |
| Mar 2015 | - | $29.44 B(+6.8%) |
| Dec 2014 | $27.57 B(+8.5%) | $27.57 B(+0.9%) |
| Sep 2014 | - | $27.34 B(-1.3%) |
| Jun 2014 | - | $27.70 B(-8.4%) |
| Mar 2014 | - | $30.24 B(+19.0%) |
| Dec 2013 | $25.41 B(-17.7%) | $25.41 B(-4.5%) |
| Sep 2013 | - | $26.60 B(-1.7%) |
| Jun 2013 | - | $27.06 B(-1.6%) |
| Mar 2013 | - | $27.49 B(-11.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $30.88 B(+8.7%) | $30.88 B(-4.0%) |
| Sep 2012 | - | $32.16 B(+9.6%) |
| Jun 2012 | - | $29.33 B(+1.7%) |
| Mar 2012 | - | $28.85 B(+1.6%) |
| Dec 2011 | $28.41 B(-1.7%) | $28.41 B(-3.4%) |
| Sep 2011 | - | $29.41 B(+0.4%) |
| Jun 2011 | - | $29.29 B(-1.3%) |
| Mar 2011 | - | $29.66 B(+2.7%) |
| Dec 2010 | $28.89 B(+55.6%) | $28.89 B(-6.1%) |
| Sep 2010 | - | $30.75 B(+32.1%) |
| Jun 2010 | - | $23.28 B(+0.6%) |
| Mar 2010 | - | $23.15 B(+24.6%) |
| Dec 2009 | $18.57 B(+63.5%) | $18.57 B(-4.6%) |
| Sep 2009 | - | $19.47 B(+5.7%) |
| Jun 2009 | - | $18.43 B(+10.0%) |
| Mar 2009 | - | $16.75 B(+47.5%) |
| Dec 2008 | $11.36 B(+20.6%) | $11.36 B(+0.3%) |
| Sep 2008 | - | $11.33 B(-6.5%) |
| Jun 2008 | - | $12.11 B(+21.2%) |
| Mar 2008 | - | $10.00 B(+6.2%) |
| Dec 2007 | $9.41 B(-10.2%) | $9.41 B(-5.3%) |
| Sep 2007 | - | $9.94 B(-9.4%) |
| Jun 2007 | - | $10.98 B(+6.9%) |
| Mar 2007 | - | $10.27 B(-2.0%) |
| Dec 2006 | $10.48 B(+13.4%) | $10.48 B(-12.4%) |
| Sep 2006 | - | $11.96 B(-0.4%) |
| Jun 2006 | - | $12.01 B(+26.3%) |
| Mar 2006 | - | $9.50 B(+2.9%) |
| Dec 2005 | $9.24 B(-0.9%) | $9.24 B(-11.8%) |
| Sep 2005 | - | $10.47 B(+4.7%) |
| Jun 2005 | - | $10.01 B(+12.9%) |
| Mar 2005 | - | $8.86 B(-5.0%) |
| Dec 2004 | $9.32 B(-1.6%) | $9.32 B(-1.1%) |
| Sep 2004 | - | $9.43 B(+0.3%) |
| Jun 2004 | - | $9.40 B(-1.3%) |
| Mar 2004 | - | $9.52 B(+0.5%) |
| Dec 2003 | $9.48 B(+12.6%) | $9.48 B(-0.7%) |
| Sep 2003 | - | $9.54 B(+1.5%) |
| Jun 2003 | - | $9.40 B(+3.2%) |
| Mar 2003 | - | $9.11 B(+8.2%) |
| Dec 2002 | $8.42 B(+36.7%) | $8.42 B(+20.8%) |
| Sep 2002 | - | $6.97 B(-0.8%) |
| Jun 2002 | - | $7.02 B(+14.0%) |
| Dec 2001 | $6.16 B(+3.4%) | $6.16 B(+6.4%) |
| Jun 2001 | - | $5.79 B(-2.9%) |
| Dec 2000 | $5.96 B(-11.1%) | $5.96 B(-10.3%) |
| Jun 2000 | - | $6.64 B |
| Dec 1999 | $6.70 B(-4.4%) | - |
| Dec 1998 | $7.01 B | - |
FAQ
- What is Novartis AG annual total long term liabilities?
- What is the all time high annual total long term liabilities for Novartis AG?
- What is Novartis AG annual total long term liabilities year-on-year change?
- What is Novartis AG quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Novartis AG?
- What is Novartis AG quarterly long term liabilities year-on-year change?
What is Novartis AG annual total long term liabilities?
The current annual total long term liabilities of NVS is $29.43 B
What is the all time high annual total long term liabilities for Novartis AG?
Novartis AG all-time high annual total long term liabilities is $38.05 B
What is Novartis AG annual total long term liabilities year-on-year change?
Over the past year, NVS annual total long term liabilities has changed by +$2.62 B (+9.79%)
What is Novartis AG quarterly total long term liabilities?
The current quarterly long term liabilities of NVS is $29.43 B
What is the all time high quarterly long term liabilities for Novartis AG?
Novartis AG all-time high quarterly total long term liabilities is $43.29 B
What is Novartis AG quarterly long term liabilities year-on-year change?
Over the past year, NVS quarterly total long term liabilities has changed by +$2.62 B (+9.79%)